Linear Interstitial Keratitis – A Retrospective Chart Review of a Rare Entity
Klinische Monatsblätter für Augenheilkunde · 01.04.2026 · 243 (04) · 340-349
DOI: 10.1055/a-2751-3309 ↗Kurz gefasst
Fachartikel in der Zeitschrift Klinische Monatsblätter für Augenheilkunde, erschienen am 01.04.2026. Verfasst von Frank Blaser und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, University Hospital Zurich, University of Zurich, Switzerland. Hauptthemen laut MEDLINE: Keratitis.
Abstract (Originalsprache)
Background
Linear interstitial keratitis (LIK) is a rare variant of interstitial keratitis and is characterised by a sharply demarcated stromal band of opacity with uncertain pathophysiology and no consensus management. We report the largest contemporary study to characterise phenotype, diagnostics, treatment, and outcomes.
Methods
This is a retrospective, investigator-initiated study across two university hospitals. Extracted data included demographics, clinical features, microbiology/serology, anterior segment imaging, treatments and outcomes.
Results
Six unilateral cases were included (five males, one female). LIK presented as a sharply demarcated linear stromal opacity of variable, often near limbus-to-limbus, extent. AS-OCT commonly localised the lesion to the anterior stroma, while IVCM (when performed) suggested broader stromal activation, despite an anterior-predominant OCT signal. Corneal scraping, as well as systemic workup, was mostly unremarkable. Management frequently combined topical corticosteroids with topical antimicrobials and/or systemic antivirals. One patient received steroid-sparing maintenance with topical 0.1% cyclosporin. Visual outcomes were generally favourable: four eyes achieved or maintained corrected Snellen ≥ 1.0. However, two eyes declined (to 0.6 and 0.5), and one patient experienced two corneal perforations during a relapsing course.
Conclusions
LIK is a recognisable, predominantly anterior stromal, phenotype of interstitial keratitis affecting predominantly younger patients. An immune-stromal process is assumed, but a clear cause could not be established despite extensive testing. Most cases are steroid-responsive but may relapse, supporting slow tapering and consideration of steroid-sparing prophylaxis. Close monitoring is warranted when thinning, neovascularisation, or recurrence is present.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Ophthalmology, University Hospital Zurich, University of Zurich, Switzerland.
- Ophthalmology, Augenklinik Wettingen, Switzerland.
- Ophthalmology, University Hospital Basel, Switzerland.
ORCID-Profile: Julia Victoria Bugajska, Daniel Barthelmes
Zitieren
APA
Blaser, F., Said, S., Bugajska, J. V., Barthelmes, D., Auw-Hädrich, C., Zweifel, S., & Meienberger, N. (2026). Linear Interstitial Keratitis – A Retrospective Chart Review of a Rare Entity. Klinische Monatsblätter für Augenheilkunde, 243(04), 340-349. https://doi.org/10.1055/a-2751-3309
Vancouver
Blaser F, Said S, Bugajska JV, Barthelmes D, Auw-Hädrich C, Zweifel S, et al. Linear Interstitial Keratitis – A Retrospective Chart Review of a Rare Entity. Klinische Monatsblätter für Augenheilkunde. 2026;243(04):340-349. doi:10.1055/a-2751-3309
BibTeX
@article{Blaser2026,
author = {Blaser, Frank and Said, Sadiq and Bugajska, Julia Victoria and Barthelmes, Daniel and Auw-Hädrich, Claudia and Zweifel, Sandrine and Meienberger, Nina},
title = {Linear Interstitial Keratitis – A Retrospective Chart Review of a Rare Entity},
journal = {Klinische Monatsblätter für Augenheilkunde},
year = {2026},
volume = {243},
number = {04},
pages = {340--349},
doi = {10.1055/a-2751-3309}
}
EUVIMED